Pages that link to "Q28205045"
The following pages link to Oxidized neprilysin in aging and Alzheimer's disease brains (Q28205045):
Displaying 49 items.
- beta-Amyloid degradation and Alzheimer's disease (Q21284467) (← links)
- The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it? (Q21296650) (← links)
- 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product (Q26782039) (← links)
- Clearance systems in the brain-implications for Alzheimer disease (Q26801541) (← links)
- (Q28161175) (redirect page) (← links)
- Amyloid Beta Annular Protofibrils in Cell Processes and Synapses Accumulate with Aging and Alzheimer-Associated Genetic Modification (Q30157432) (← links)
- The role of magnesium deficiency in cardiovascular and intestinal inflammation (Q30448185) (← links)
- Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation (Q33267617) (← links)
- Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells (Q33642530) (← links)
- Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology (Q33646882) (← links)
- Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease (Q33915362) (← links)
- Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain (Q34130147) (← links)
- Decreased Proteolytic Activity of the Mitochondrial Amyloid-β Degrading Enzyme, PreP Peptidasome, in Alzheimer's Disease Brain Mitochondria (Q34199931) (← links)
- Altered NEP2 Expression and Activity in Mild Cognitive Impairment and Alzheimer's Disease (Q34225229) (← links)
- N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells (Q34581928) (← links)
- Decreased Neprilysin and Pulmonary Vascular Remodeling in Chronic Obstructive Pulmonary Disease (Q34665155) (← links)
- Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition (Q35087794) (← links)
- Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease (Q35537887) (← links)
- Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome (Q35677159) (← links)
- Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease (Q35698618) (← links)
- Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme (Q35994771) (← links)
- Microglial Inhibitory Mechanism of Coenzyme Q10 Against Aβ (1-42) Induced Cognitive Dysfunctions: Possible Behavioral, Biochemical, Cellular, and Histopathological Alterations (Q36260932) (← links)
- Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease (Q36579852) (← links)
- Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer's disease. (Q37089706) (← links)
- Distinct subcellular patterns of neprilysin protein and activity in the brains of Alzheimer's disease patients, transgenic mice and cultured human neuronal cells (Q37205562) (← links)
- Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells (Q37219722) (← links)
- Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia (Q37238403) (← links)
- Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease (Q37408544) (← links)
- Activation of proinflammatory signaling by 4-hydroxynonenal-Src adducts in aged kidneys (Q37588205) (← links)
- Aspects of beta-amyloid as a biomarker for Alzheimer's disease (Q37755129) (← links)
- Elevation of glutathione as a therapeutic strategy in Alzheimer disease (Q37947939) (← links)
- Proteolytic degradation of amyloid β-protein (Q38016899) (← links)
- Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease (Q38123911) (← links)
- Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications (Q38601445) (← links)
- Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, an (Q39627415) (← links)
- White matter hypoperfusion and damage in dementia: post-mortem assessment (Q41674220) (← links)
- Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines (Q41961695) (← links)
- HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes (Q42130528) (← links)
- Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach (Q42223118) (← links)
- Neprilysin deficiency-dependent impairment of cognitive functions in a mouse model of amyloidosis (Q43865743) (← links)
- Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice (Q47098610) (← links)
- Neprylisin decreases uniformly in Alzheimer's disease and in normal aging (Q48729149) (← links)
- Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging (Q48887111) (← links)
- Complementary distributions of amyloid-beta and neprilysin in the brains of dogs and cats (Q49141792) (← links)
- The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin (Q50059412) (← links)
- The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease. (Q52147741) (← links)
- Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review (Q58549216) (← links)
- Role of amyloid-β–metal interactions in Alzheimer’s disease (Q58842294) (← links)
- Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress (Q92384162) (← links)